Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The Harmony transcatheter pulmonary valve (TPV) is designed to treat severe pulmonary regurgitation in the native or surgically repaired right ventricular (RV) outflow tract. Early outcomes after TPV replacement with the Harmony valve have been positive, but longer-term data are limited.
Methods: The study included patients who received a commercially available TPV22 or TPV25 device as part of the nonrandomized, prospective Native Outflow Tract Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study. Patients completed at least 3 years of follow-up, and outcomes to 5 years were reported when available.
Results: Eighty-nine patients were catheterized, and 86 were successfully implanted with a Harmony TPV. Median duration of follow-up was 5 (range 0-6) years in the TPV22 group and 3 (1-4) years in the TPV25 group. At 3 years, all patients with a TPV22 and 96% of those with a TPV25 had ≤mild pulmonary regurgitation. By magnetic resonance imaging, significant improvements from preimplant to 2 years were observed in RV end-diastolic volume index, RV to left ventricular end-diastolic volume ratio, and effective RV stroke volume (all <0.001). SF-36 quality-of-life scores improved after Harmony implantation and were sustained over 3 years. Early cases of ventricular tachycardia resolved, and there were no new arrhythmias. Adverse events up to 5 years included 3 deaths unrelated to the device or procedure, 2 cases of endocarditis that were treated (1 medically, 1 transcatheter debulking of a vegetation) and resolved, 6 patients with RV outflow tract obstruction and thrombosis resulting in valve-in valve procedures, and 1 major stent fracture resulting in surgical explant.
Conclusions: At 3 to 5 years, Harmony TPV replacement resulted in sustained valve competence, beneficial cardiac remodeling, and improved quality of life. Continued monitoring is needed to assess long-term outcomes and valve performance.
Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01762124; NCT02979587.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/CIRCINTERVENTIONS.125.015196 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients.
Circ Cardiovasc Interv
July 2025
Department of Cardiothoracic Surgery, Stanford University Medical Center, CA (D.B.M.E.).
Background: The Harmony transcatheter pulmonary valve (TPV) is designed to treat severe pulmonary regurgitation in the native or surgically repaired right ventricular (RV) outflow tract. Early outcomes after TPV replacement with the Harmony valve have been positive, but longer-term data are limited.
Methods: The study included patients who received a commercially available TPV22 or TPV25 device as part of the nonrandomized, prospective Native Outflow Tract Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study.
Successful Transcatheter Pulmonary Valve Implantation in a Patient with Mechanical Valve in Aortic Position: A Case Report.
Intern Med
June 2025
Department of Pediatric Cardiology and Adults with Congenital Heart Disease, Sakakibara Heart Institute, Japan.
The Harmony™ transcatheter pulmonary valve (TPV) is specifically designed to treat severe pulmonary regurgitation in a native or surgically repaired right ventricular outflow tract. To date, no reports have described TPV implantation (TPVI) in patients with prior aortic valve replacement (AVR) using a mechanical valve. Therefore, the risks of technical challenges or complications, particularly coronary compression or device fracture associated with prior AVR, remain unknown.
View Article and Find Full Text PDFProgress With New Challenges: Self-Expanding Transcatheter Pulmonary Valve Endocarditis.
JACC Case Rep
May 2025
Section of Congenital Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Background: The Harmony (Medtronic) self-expanding transcatheter pulmonary valve is the first Food and Drug Administration-approved transcatheter valve system designed to treat severe pulmonary regurgitation (PR) in patients with a native or surgically repaired right ventricular outflow tract. The valve greatly expands transcatheter interventions to patients with residual PR after childhood surgical interventions; the risk and treatment of endocarditis with this therapy are still unclear.
Summary: In this report, we describe to our knowledge the first published details and images of surgical explantation of this valve with an extensive skirt extending into the right ventricular outflow tract myocardium and pulmonary artery.
Transcatheter Pulmonary Valve Implantation in Congenital Heart Diseases: Current Advances and Future Prospectives.
Children (Basel)
April 2025
Pediatric Cardiology Unit, AORN "Ospedali dei Colli", Monaldi Hospital, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.
Pulmonary disfunction is frequent in repaired congenital heart diseases. Both pulmonary regurgitation and pulmonary stenosis are possible complications over time. In the past, the surgical approach was the only feasible management but exposed the patient to a redo-surgery with its consequent risks.
View Article and Find Full Text PDFComparison Between Gated Cardiac Magnetic Resonance Angiography and Computed Tomography Angiography for Harmony Valve Anatomic Fit Analysis.
Catheter Cardiovasc Interv
August 2025
Betty Irene Moore Heart Center, Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California, USA.
Aims: To determine if electrocardiogram (ECG)-gated magnetic resonance angiography (MRA) can be used to assess candidacy for transcatheter pulmonary valve replacement with the Harmony valve.
Background: Anatomic fit assessment for the Harmony valve is conducted with retrospectively gated computed tomography angiography (CTA). The suitability of MRA for this purpose has not been assessed.